activins has been researched along with piperidines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Clark, BJ; Cochrum, RK; Ghooray, DT; Moore, JP; Tseng, MT; Winters, SJ | 1 |
| Aikawa, N; Suzuki, Y; Takaba, K | 1 |
| Chang, CC; Chang, J; Ho, SY; Hsieh, CH; Hsu, MH; Huang, RC; Jackson, TL; Liao, KW; Lin, YL; Mold, DE; Tsai, NM; Wu, HY | 1 |
| El-Kerdasy, HI; Hussien, NI; Ibrahim, ME | 1 |
4 other study(ies) available for activins and piperidines
| Article | Year |
|---|---|
Effects of CDB-4022 on Leydig cell function in adult male rats.
Topics: Activins; Animals; Cell Line, Tumor; Gene Expression Profiling; Gonadal Steroid Hormones; Indenes; Inhibins; Leydig Cells; Male; Mice; Phosphoproteins; Piperidines; Pituitary Gland; Rats; Rats, Sprague-Dawley; RNA; Steroid 17-alpha-Hydroxylase | 2007 |
A Simple Protocol for the Myocardial Differentiation of Human iPS Cells.
Topics: Activins; Bone Morphogenetic Protein 4; Calcium Channel Blockers; Carrier Proteins; Cell Differentiation; Cells, Cultured; Chromans; Embryoid Bodies; Homeobox Protein Nkx-2.5; Homeodomain Proteins; Humans; Induced Pluripotent Stem Cells; Myocardium; Pentamidine; Piperidines; Potassium Channel Blockers; Pyridines; Sulfonamides; Transcription Factors; Troponin T; Verapamil; Wnt3A Protein | 2015 |
In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.
Topics: Activins; Animals; Antibodies, Neoplasm; Antineoplastic Agents; Autoantibodies; B-Cell Activating Factor; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Epoxide Hydrolases; Female; Gene Expression; Immunity, Humoral; Immunologic Factors; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phenyl Ethers; Piperidines; Signal Transduction; Tumor Burden | 2016 |
Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin.
Topics: Activins; Animals; Biomarkers; Cannabinoid Receptor Antagonists; Cytoprotection; Disease Models, Animal; Follistatin; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Transforming Growth Factor beta | 2017 |